background national emphysema treatment trial nett marked variability response lung volume reduction surgery lvrs observed sought identify genetic differences explain variability methods NUMBER subjects nett genetics ancillary study outcome measures used define response lvrs months modified bode index fev1 maximum work achieved cardiopulmonary exercise test university california san diego shortness breath questionnaire single nucleotide polymorphisms snps genotyped genes previously shown associated chronic obstructive pulmonary disease susceptibility exercise capacity emphysema distribution results snp upstream glutathione pi gstp1 p NUMBER coding snp microsomal epoxide hydrolase ephx1 p NUMBER associated change bode score effects appeared strongest patients lobe predominant low exercise subgroup promoter snp ephx1 associated change bode score p NUMBER strongest effects patients upper lobe predominant emphysema low exercise capacity additional snp gstp1 additional snps ephx1 associated p NUMBER additional lvrs outcomes snp effects seen NUMBER patients randomized medical therapy conclusion genetic variants gstp1 ephx1 genes encoding xenobiotic metabolizing enzymes predictive response lvrs polymorphisms identify patients likely benefit lvrs post bronchodilator s transferase non upper